LOW-DOSE IL-2 RESTORES TREG-MEDIATED IMMUNE TOLERANCE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

被引:1
|
作者
Wu, R. [1 ]
Su, R. [1 ]
Ding, T. [1 ]
Xue, H. [1 ]
An, J. [1 ]
Jiang, L. [1 ]
Li, X. F. [1 ]
Wang, C. [1 ]
机构
[1] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China
关键词
D O I
10.1136/annrheumdis-2020-eular.4346
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0278
引用
收藏
页码:1079 / 1080
页数:2
相关论文
共 50 条
  • [21] Low-dose IL-2 in the treatment of immune-related diseases
    Zhang, Jiakui
    Huang, Yong
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [22] Low-dose IL-2 for patients with systemic lupus erythematosus
    He, Jing
    Sun, Xiaolin
    Li, Zhanguo
    LANCET RHEUMATOLOGY, 2019, 1 (04): : E203 - E203
  • [23] Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis
    Mansfield, Nicholas
    Hamour, Sally
    Habib, Anne-Marie
    Tarzi, Ruth
    Levy, Jeremy
    Griffith, Megan
    Cairns, Tom
    Cook, H. Terence
    Pusey, Charles D.
    Salama, Alan D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3280 - 3286
  • [24] Low-dose chidamide restores immune tolerance in ITP in mice and humans
    Zhao, Hong-yu
    Ma, Ya-hui
    Li, Da-qi
    Sun, Tao
    Li, Li-zhen
    Li, Ping
    Liu, Xin-guang
    Zhou, Hai
    Hou, Yu
    Liu, Yang
    Han, Pan-pan
    Zhao, Ya-jing
    Jing, Fang-miao
    Peng, Jun
    Hou, Ming
    BLOOD, 2019, 133 (07) : 730 - 742
  • [25] Low-Dose IL-2 in the Treatment of Lupus
    Masayuki Mizui
    George C. Tsokos
    Current Rheumatology Reports, 2016, 18
  • [26] Local low-dose IL-2 therapy
    Den Otter, W
    Balemans, L
    Battermann, JJ
    Bernsen, MR
    Cadee, JA
    Dobrowolski, Z
    Everse, LA
    Fiszer-Maliszewska, L
    Gavhumende, R
    De Groot, JW
    De Groot, K
    Hennink, WE
    Hill, FWG
    Jurgenliemp-Schulz, I
    Klein, WR
    Koten, JW
    Maas, RA
    Steerenberg, P
    Stewart, R
    Zembala, M
    HEPATO-GASTROENTEROLOGY, 1999, 46 : 1280 - 1286
  • [27] Low-Dose IL-2 in the Treatment of Lupus
    Mizui, Masayuki
    Tsokos, George C.
    CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (11)
  • [28] Abnormal Expression Pattern of the IL-2 Receptor β-Chain on CD4+ T Cells in ANCA-Associated Vasculitis
    Wilde, Benjamin
    Hoerning, Andre
    Kribben, Andreas
    Witzke, Oliver
    Dolff, Sebastian
    DISEASE MARKERS, 2014, 2014
  • [29] Plasma exchange and low cyclophosphamide dose in induction treatment of ANCA-associated systemic vasculitis
    Szpirt, Wladimir M.
    Krarup, Elisabeth
    Egfjord, Martin
    APMIS, 2009, 117 : 75 - 75
  • [30] RESTABLISHMENT OF IMMUNE TOLERANCE IN ANCA-ASSOCIATED VASCULITIS: DEFINING A COHORT WITH SUSTAINED ANCA NEGATIVITY AND DRUG FREE CLINICAL REMISSION
    Oates, Tom
    Florez-Barros, Fernanda
    Zhao, Minghui
    Rutgers, Bram
    Stegeman, Coen
    Heeringa, Peter
    Tesar, Vladimir
    Little, Mark
    Harper, Lorraine
    Hruskova, Zdenka
    Chen, Min
    Sanders, Jan-Stefan
    Salama, Alan D.
    RHEUMATOLOGY, 2017, 56